Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies.
Rizzolio S, Cagnoni G, Battistini C, Bonelli S, Isella C, Van Ginderachter JA, Bernards R, Di Nicolantonio F, Giordano S, Tamagnone L.
Rizzolio S, et al. Among authors: battistini c.
J Clin Invest. 2018 Aug 31;128(9):3976-3990. doi: 10.1172/JCI99257. Epub 2018 Aug 13.
J Clin Invest. 2018.
PMID: 29953416
Free PMC article.